IRVINE, CA--(Marketwired - Jul 30, 2013) - BIOLASE, Inc. (
U.S. Patent No. 8,485,818 is titled "Fluid Controller" and relates to a new controlled way of delivering sterile water within the fluid conditioning system of BIOLASE's revolutionary WaterLase ® systems. This technology will be used in both dental and medical cutting, irrigating, evacuating, cleaning and drilling operations. An additional important aspect of this new patent is the introduction of disinfectant agents via spray, mist, or water stream used for dental or surgical applications.
Dmitri Boutoussov, Vice-President of Research and Development commented, "The effectiveness and accuracy of WaterLase technology for clinical applications is critically dependent on the extremely precise control of the fluid flow. It is a core competency at BIOLASE and key area of differentiation for us over all other hard-tissue lasers in the market. It is challenging to precisely control fluids at very low flow levels. Inkjet printers and fuel injection systems are good examples of successful products in other industries. Our ability to meet these challenges expands our ability to leverage this technology into our targeted non-dental medical markets where the use of sterile fluids is mandatory."
"Off-the-shelf solutions were not able to meet our exacting requirements, which motivated us to develop a whole new approach to precisely control fluid flow with an integrated sterile and disposable design. Success in practical implementation of our concept will open doors for new medical applications of our laser technology," concluded Boutoussov.
Federico Pignatelli, Chairman and Chief Executive Officer, said, "This is an exciting patent for BIOLASE. This latest patented technology is a departure from conventional fluid flow control systems and is expected to advance the efficacy and safety of laser related surgical procedures where sterile fluids are required. Further, while the ability to use the WaterLase for dental and medical indications requiring a sterile water system is a major advance, our IP in this patent family also covers fluid conditioning with disinfectants, flavors, antibiotics and other conditioned fluid particles which hold promise for future applications."
This is the fifth U.S. patent issued in relation to groundbreaking fluid conditioning laser technology with an additional U.S. patent application pending.
About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and medicine . The Company's proprietary laser products incorporate over 350 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaginative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 22,500 lasers. Other laser products under development address ophthalmology and other medical and consumer markets.
For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com , Facebook at www.facebook.com/biolaseinc , Twitter at www.twitter.com/biolaseinc , Pinterest at www.pinterest.com/biolase , LinkedIn at www.linkedin.com/company/biolase , Instagram at www.instagram.com/biolaseinc and YouTube at www.youtube.com/biolasevideos .
BIOLASE ® and WaterLase ® are registered trademarks of BIOLASE, Inc.
For further information, please contact: Michael Porter Porter, LeVay & Rose, Inc. 212-564-4700
